Publicaciones en colaboración con investigadores/as de Hospital de Galdakao - Usansolo (53)

2024

  1. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database

    British Journal of Clinical Pharmacology, Vol. 90, Núm. 7, pp. 1751-1755

  2. Analysis of the evolution of outpatient pharmaceutical care in hospital pharmacy services in Spain after the implementation and development of the MAPEX initiative

    Journal of Healthcare Quality Research, Vol. 39, Núm. 2, pp. 65-79

  3. Biosimilars and access to biologic therapy in immune-mediated diseases

    Expert Opinion on Biological Therapy, Vol. 24, Núm. 7, pp. 647-653

  4. Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis

    Medicina Clinica

  5. Incorporating the One Health philosophy into pharmacovigilanc: Pharmacovigilance

    British Journal of Clinical Pharmacology

  6. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

  7. Psychometric characteristics of the Spanish version of the HIV Symptom Index

    Journal of patient-reported outcomes, Vol. 8, Núm. 1, pp. 116

2019

  1. Pilot study to develop and validate a questionnaire based on HIV symptoms index

    Farmacia Hospitalaria, Vol. 43, Núm. 3, pp. 87-93

  2. Reply: On the safety of intravenous iron formulations

    Medicina Clinica

2018

  1. Kounis syndrome induced by ranitidine

    Medicina Clinica

2017

  1. Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

    European Journal of Clinical Pharmacology, Vol. 73, Núm. 9, pp. 1159-1164

2016

  1. Evaluación de la causalidad en las comunicaciones de reacciones adversas a medicamentos. Algoritmo del Sistema Español de Farmacovigilancia

    Medicina Clinica, Vol. 147, Núm. 10, pp. 461-464

2015

  1. Adherence in patients with chronic treatment: Data of “Adherence Day 2013”

    Farmacia Hospitalaria, Vol. 39, Núm. 2, pp. 109-113

  2. Adverse reactions to antipsychotics in parkinson disease: An analysis of the Spanish Pharmacovigilance database

    Clinical Neuropharmacology, Vol. 38, Núm. 3, pp. 69-84

  3. Anticholinergic burden in Parkinson's disease inpatients

    European Journal of Clinical Pharmacology, Vol. 71, Núm. 10, pp. 1271-1277

2014

  1. Effect of Concomitant Use of Montelukast and Efavirenz on Neuropsychiatric Adverse Events

    Annals of Pharmacotherapy, Vol. 48, Núm. 1, pp. 145-148

  2. Papel del aprepitant en el manejo del prurito en un paciente con linfoma cutáneo de células T

    Farmacia Hospitalaria

  3. Situación actual de la estructura, procesos y resultados de la atención farmacéutica al paciente VIH en España. Proyecto origen

    Farmacia Hospitalaria, Vol. 38, Núm. 2, pp. 89-99

2013

  1. Antipsychotics and seizures: Higher risk with atypicals?

    Seizure, Vol. 22, Núm. 2, pp. 141-143

  2. Comments on Duran et al.'s systematic review of anticholinergic risk scales (EJCP 2DOI 10.1007/s00228-013-1499-3)

    European Journal of Clinical Pharmacology